Financial Information

Sign up to receive the latest news and updates from NervGen
 
 
 
Latest Financial Results
Q2 2019

Quarter Ended June 30, 2019

Financial Statements
MD&A
Balance Sheet
Income Statement
Cash Flow
Past Financial Results
Q1 2019

Quarter Ended March 31, 2019

Financial Statements
MD&A
2018

Year Ended December 31, 2018

Financial Statements
MD&A
Q3 2018

Quarter Ended September 30, 2018

Financial Statements
MD&A
Q2 2018

Quarter Ended June 30, 2018

Financial Statements
MD&A
2017

Incorporation to December 31, 2017

Financial Statements
MD&A
Additional Documents

© 2019

TSX.V: NGEN

OTCQX: NGENF

Website last updated November 21, 2019. The information posted was accurate at the time of posting, but may be superseded by subsequent disclosures.  

This website may include predictions, estimates or other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements. Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these forward looking statements in light of new information or future events. You should also review our most recent filings on SEDAR (www.sedar.com) for a more complete discussion of these factors and other risks, particularly under the heading “Risk Factors.”